2seventy bio, Inc. (TSVT)
May 13, 2025 - TSVT was delisted (reason: acquired by BMY)
5.00
0.00 (0.00%)
Inactive · Last trade price on May 12, 2025

2seventy bio Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for 2seventy bio stock had an average target of 6.50, with a low estimate of 5.00 and a high estimate of 11.

Price Target: $6.50 (+30.00%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$5.00$6.50$5.00$11
Change0.00%+30.00%0.00%+120.00%
* Price targets were last updated on Mar 14, 2025.

Analyst Ratings

The average analyst rating for 2seventy bio stock from 4 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

RatingDec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy222221
Buy111000
Hold555333
Sell000000
Strong Sell000000
Total888554

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Maintains
$6$5
HoldMaintains$6$5n/aMar 14, 2025
Leerink Partners
Leerink Partners
Hold
Downgrades
$9$5
HoldDowngrades$9$5n/aMar 11, 2025
Morgan Stanley
Morgan Stanley
Hold
Maintains
$7$6
HoldMaintains$7$6+20.00%Jul 29, 2024
Wedbush
Wedbush
Hold
Reiterates
$5
HoldReiterates$5n/aJun 27, 2024
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$12$11
Strong BuyMaintains$12$11+120.00%May 9, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
69.85M
from 37.86M
Increased by 84.48%
Revenue Next Year
76.62M
from 69.85M
Increased by 9.69%
EPS This Year
-0.47
from -1.10
EPS Next Year
-0.24
from -0.47
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
248.12M54.52M91.50M100.39M37.86M69.85M76.62M
Revenue Growth
460.15%-78.03%67.82%9.72%-62.28%84.48%9.69%
EPS
-5.14-12.44-7.13-4.42-1.10-0.47-0.24
EPS Growth
-------
Forward PE
-------
No. Analysts
-----76
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High94.4M109.3M
Avg69.8M76.6M
Low52.5M53.3M

Revenue Growth

Revenue Growth20252026202720282029
High
149.3%
56.5%
Avg
84.5%
9.7%
Low
38.7%
-23.7%

EPS Forecast

EPS20252026202720282029
High-0.220.17
Avg-0.47-0.24
Low-0.86-0.76

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.